Guidant Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Guidant Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$29K	Sell	100 -9	-8%	-$2.58K	0.01%	202
2019 Q2	$32K	Hold	109	–	–	0.01%	198
2019 Q1	$30K	Buy	109 +9	+9%	+$2.24K	0.01%	198
2018 Q4	$22K	Sell	100 -7	-7%	-$1.64K	0.01%	161
2018 Q3	$26K	Hold	107	–	–	0.01%	106
2018 Q2	$21K	Hold	107	–	–	0.01%	115
2018 Q1	$21K	Buy	107 +7	+7%	+$1.47K	0.01%	110
2017 Q4	$20K	Hold	100	–	–	0.01%	119
2017 Q3	$19K	Hold	100	–	–	0.01%	121
2017 Q2	$17K	Hold	100	–	–	0.01%	169
2017 Q1	$15K	Hold	100	–	–	0.01%	156
2016 Q4	$15K	Hold	100	–	–	0.01%	139
2016 Q3	$16K	Buy	+100	New	+$15.4K	0.01%	137

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Guidant Wealth Advisors's TMO Position: Q3 2019 in Review

Guidant Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 8.3% in Q3 2019, selling an estimated $2.58K and leaving 100 shares worth $29K. The position accounts for 0.01% of the portfolio, ranked #202.

Guidant Wealth Advisors first reported a position in TMO in Q3 2016 and has held it in 13 quarters since. The position peaked at $32K in Q2 2019. 1,543 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

Guidant Wealth Advisors held 100 shares of Thermo Fisher Scientific worth $29K as of Q3 2019.
Guidant Wealth Advisors sold 9 Thermo Fisher Scientific shares in Q3 2019, an estimated $2.58K.
Thermo Fisher Scientific made up 0.01% of Guidant Wealth Advisors's portfolio in Q3 2019, its #202 holding.
Guidant Wealth Advisors first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 13 quarters since.
Guidant Wealth Advisors's Thermo Fisher Scientific position peaked at $32K in Q2 2019.
1,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on Guidant Wealth Advisors's 13F filing for Q3 2019, filed 16 Oct 2019.